Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 63

1.

Antihypertensive drugs and inflammation in acute ischemic stroke as a predictor factor of future cardiovascular mortality.

Benbir G, Ince B, Kumral E, Ongen Z, Kultursay H, Tokgozoglu L, Oto A, Tuzun H; ARDA Investigators..

Inflammation. 2012 Feb;35(1):65-73. doi: 10.1007/s10753-010-9290-4.

PMID:
21240546
2.

Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group.

Zanchetti A, Hansson L, Dahlöf B, Elmfeldt D, Kjeldsen S, Kolloch R, Larochelle P, McInnes GT, Mallion JM, Ruilope L, Wedel H.

J Hypertens. 2001 Jun;19(6):1149-59.

PMID:
11403365
3.

Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: the 'Bergen stroke study'.

Idicula TT, Brogger J, Naess H, Waje-Andreassen U, Thomassen L.

BMC Neurol. 2009 Apr 28;9:18. doi: 10.1186/1471-2377-9-18.

4.

Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003.

Staessen JA, Wang JG, Thijs L.

J Hypertens. 2003 Jun;21(6):1055-76.

PMID:
12777939
6.

The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.

Thomas GN, Chan P, Tomlinson B.

Drugs Aging. 2006;23(2):131-55. Review.

PMID:
16536636
7.

Antihypertensive treatment and stroke prevention: are angiotensin receptor blockers superior to other antihypertensive agents?

Armario P, de la Sierra A.

Ther Adv Cardiovasc Dis. 2009 Jun;3(3):197-204. doi: 10.1177/1753944709104164. Epub 2009 May 14. Review.

PMID:
19443514
8.

Blood pressure in acute ischemic stroke and mortality: a study with noninvasive blood pressure monitoring.

Sartori M, Benetton V, Carraro AM, Calò LA, Macchini L, Giantin V, Tosato F, Pessina AC, Semplicini A.

Blood Press Monit. 2006 Aug;11(4):199-205.

PMID:
16810030
9.
10.
11.

The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study.

Kjeldsen SE, Lyle PA, Kizer JR, Dahlöf B, Devereux RB, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Snapinn SM, Harris KE, Wedel H; LIFE Study Group..

J Clin Hypertens (Greenwich). 2005 Mar;7(3):152-8.

12.
13.

Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.

Devereux RB, de Faire U, Fyhrquist F, Harris KE, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Hille DA, Dahlöf B.

Curr Med Res Opin. 2007 Feb;23(2):259-70.

PMID:
17288679
14.

Relationship between ambulatory blood pressure and follow-up clinic blood pressure in elderly patients with systolic hypertension.

Fagard RH, Staessen JA, Thijs L, Bulpitt CJ, Clement D, de Leeuw PW, Jääskivi M, Mancia G, O'Brien E, Palatini P, Tuomilehto J, Webster J; Systolic Hypertension in Europe Trial Investigators..

J Hypertens. 2004 Jan;22(1):81-7.

PMID:
15106798
15.

Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.

Ekbom T, Linjer E, Hedner T, Lanke J, De Faire U, Wester PO, Dahlöf B, Scherstén B.

Blood Press. 2004;13(3):137-41.

PMID:
15223721
16.

Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly.

Kaplan RC, Tirschwell DL, Longstreth WT Jr, Manolio TA, Heckbert SR, Lefkowitz D, El-Saed A, Psaty BM.

Neurology. 2005 Sep 27;65(6):835-42. Erratum in: Neurology. 2006 Feb 28;66(4):493.

PMID:
16186519
17.

Incomplete benefit of antihypertensive therapy on stroke reduction in older hypertensives with abnormal nocturnal blood pressure dipping (extreme-dippers and reverse-dippers).

Hoshide Y, Kario K, Schwartz JE, Hoshide S, Pickering TG, Shimada K.

Am J Hypertens. 2002 Oct;15(10 Pt 1):844-50.

PMID:
12372670
18.

Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.

Almgren T, Persson B, Wilhelmsen L, Rosengren A, Andersson OK.

J Intern Med. 2005 Jun;257(6):496-502.

19.

Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.

Kim SH, Chung WY, Zo JH, Kim MA, Chang HJ, Cho YS, Youn TJ, Chae IH, Choi DJ, Gwak JJ, Lee HY, Park JS, Kang HJ, Kim YJ, Kim HS.

Clin Ther. 2009 May;31(5):988-98. doi: 10.1016/j.clinthera.2009.05.020.

PMID:
19539099

Supplemental Content

Support Center